Statements

2025

SAMHSA Statement on 988 Press 3 Option - June 17, 2025

DEA and HHS Issue Final Telemedicine Rule for Buprenorphine Access - January 17, 2025

2024

DEA and HHS Extend Telemedicine Flexibilities through 2025 - November 15, 2024

2021

Statement on 42 CFR Part 2 Amendments Process - April 9, 2021

Last Updated: 06/17/2025